Jaguar Health (NASDAQ:JAGX) Trading 7.9% Higher

Share on StockTwits

Jaguar Health Inc (NASDAQ:JAGX)’s share price traded up 7.9% on Friday . The stock traded as high as $0.81 and last traded at $0.79, 436,282 shares traded hands during mid-day trading. A decline of 13% from the average session volume of 504,344 shares. The stock had previously closed at $0.73.

Several research analysts recently weighed in on the company. Zacks Investment Research lowered Jaguar Health from a “hold” rating to a “sell” rating in a research report on Tuesday. LADENBURG THALM/SH SH began coverage on Jaguar Health in a research report on Thursday, September 12th. They set a “buy” rating and a $5.00 price target for the company. HC Wainwright set a $10.00 price target on Jaguar Health and gave the stock a “buy” rating in a research report on Tuesday, July 2nd. Finally, ValuEngine upgraded Jaguar Health from a “hold” rating to a “buy” rating in a research report on Wednesday, October 2nd.

The firm has a 50-day moving average price of $1.12 and a 200 day moving average price of $1.70. The firm has a market capitalization of $36.63 million, a PE ratio of 0.00 and a beta of 0.77. The company has a quick ratio of 0.24, a current ratio of 0.35 and a debt-to-equity ratio of 0.02.

Jaguar Health (NASDAQ:JAGX) last released its quarterly earnings results on Wednesday, August 14th. The biotechnology company reported ($9.09) EPS for the quarter, missing the consensus estimate of ($5.61) by ($3.48). Jaguar Health had a negative return on equity of 698.61% and a negative net margin of 727.27%. The firm had revenue of $1.71 million for the quarter, compared to analysts’ expectations of $3.05 million. Equities research analysts expect that Jaguar Health Inc will post -5.44 earnings per share for the current year.

In other news, Director James J. Bochnowski purchased 180,582 shares of the stock in a transaction dated Tuesday, July 23rd. The stock was acquired at an average cost of $2.00 per share, for a total transaction of $361,164.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.81% of the company’s stock.

An institutional investor recently bought a new position in Jaguar Health stock. Wedbush Securities Inc. acquired a new stake in Jaguar Health Inc (NASDAQ:JAGX) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 25,100 shares of the biotechnology company’s stock, valued at approximately $33,000. Wedbush Securities Inc. owned approximately 0.05% of Jaguar Health at the end of the most recent quarter. Institutional investors and hedge funds own 0.06% of the company’s stock.

Jaguar Health Company Profile (NASDAQ:JAGX)

Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.

Further Reading: Options Trading – Understanding Strike Price

Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Stabilus  Given a €45.00 Price Target by UBS Group Analysts
Stabilus Given a €45.00 Price Target by UBS Group Analysts
Banco Santander S.A. Sells 4,317 Shares of Ally Financial Inc
Banco Santander S.A. Sells 4,317 Shares of Ally Financial Inc
Banco Santander S.A. Has $1.29 Million Holdings in Chubb Ltd
Banco Santander S.A. Has $1.29 Million Holdings in Chubb Ltd
Regeneron Pharmaceuticals Inc  Shares Sold by Banco Santander S.A.
Regeneron Pharmaceuticals Inc Shares Sold by Banco Santander S.A.
Banco Santander S.A. Buys 17,228 Shares of eBay Inc
Banco Santander S.A. Buys 17,228 Shares of eBay Inc
HelloGold Market Cap Reaches $159,928.00
HelloGold Market Cap Reaches $159,928.00


© 2006-2019 Ticker Report